1056361000168102: Riximyo (trade product)
Status: current, Primitive. Date: 31-Dec 2017. Module: Australian Medicines Terminology module
Descriptions:
Expanded Value Set
Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Riximyo 500 mg/50 mL injection, 2 x 50 mL vials |
has TP |
True |
Riximyo |
Inferred relationship |
Some |
|
Riximyo 100 mg/10 mL injection, 2 x 10 mL vials |
has TP |
True |
Riximyo |
Inferred relationship |
Some |
|
Riximyo 100 mg/10 mL injection, 2 x 10 mL vials |
has TP |
True |
Riximyo |
Inferred relationship |
Some |
|
Riximyo 500 mg/50 mL injection, 2 x 50 mL vials |
has TP |
True |
Riximyo |
Inferred relationship |
Some |
|
Riximyo 100 mg/10 mL injection, 10 mL vial |
Is a |
True |
Riximyo |
Inferred relationship |
Some |
|
Riximyo 500 mg/50 mL injection, 50 mL vial |
Is a |
True |
Riximyo |
Inferred relationship |
Some |
|
Riximyo 500 mg/50 mL injection, 50 mL vial |
has TP |
True |
Riximyo |
Inferred relationship |
Some |
|
Riximyo 500 mg/50 mL injection, 50 mL vial |
has TP |
True |
Riximyo |
Inferred relationship |
Some |
|
Riximyo (rituximab 100 mg / 10 mL) injection, 3 x 10 mL vials (containered trade product pack) |
has TP |
True |
Riximyo |
Inferred relationship |
Some |
|
Riximyo 100 mg/10 mL injection, 3 x 10 mL vials |
has TP |
True |
Riximyo |
Inferred relationship |
Some |
|
Reference Sets
Trade product reference set
Back to Start